FAR Biotech

Ownership

Private

Therapeutic Areas

OncologyNeurologyInfectious Diseases

Stage

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Small molecules

FAR Biotech General Information

The company has validated its quantum biomodeling platform preclinically across therapeutic areas including neurodegeneration, oncology, and infectious diseases[2][5]

Contact Information

Website

https://www.farbiotech.com/

Primary Industry

Biotech

Corporate Office

Houston, Texas
United States

Drug Pipeline

No pipeline data available

For full access to FAR Biotech's pipeline data

Book a demo

Key Partnerships

Aragen Life Sciences, Johnson & Johnson (JLABS resident)

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

FAR Biotech Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more

To view FAR Biotech's complete valuation and funding history, request access »